The Current Role and Evolution of X-ray Crystallography in Drug Discovery and Development

Overview

Journal Expert Opin Drug Discov

Specialties Chemistry
Pharmacology

Date 2023 Aug 18

PMID 37592849

Authors

Vanessa Bijak

Michal Szczygiel

Joanna Lenkiewicz

Michal Gucwa

David R Cooper

Krzysztof Murzyn

Wladek Minor

Affiliations

Soon will be listed here.

Abstract

Introduction: Macromolecular X-ray crystallography and cryo-EM are currently the primary techniques used to determine the three-dimensional structures of proteins, nucleic acids, and viruses. Structural information has been critical to drug discovery and structural bioinformatics. The integration of artificial intelligence (AI) into X-ray crystallography has shown great promise in automating and accelerating the analysis of complex structural data, further improving the efficiency and accuracy of structure determination.

Areas Covered: This review explores the relationship between X-ray crystallography and other modern structural determination methods. It examines the integration of data acquired from diverse biochemical and biophysical techniques with those derived from structural biology. Additionally, the paper offers insights into the influence of AI on X-ray crystallography, emphasizing how integrating AI with experimental approaches can revolutionize our comprehension of biological processes and interactions.

Expert Opinion: Investing in science is crucially emphasized due to its significant role in drug discovery and advancements in healthcare. X-ray crystallography remains an essential source of structural biology data for drug discovery. Recent advances in biochemical, spectroscopic, and bioinformatic methods, along with the integration of AI techniques, hold the potential to revolutionize drug discovery when effectively combined with robust data management practices.

Citing Articles

Deep learning-based assessment of missense variants in the gene presented with bilateral congenital cataract.

Xiao B, Zhang S, Ainiwaer M, Liu H, Ning L, Hong Y BMJ Open Ophthalmol. 2025; 10(1.

PMID: 39809522 PMC: 11751923. DOI: 10.1136/bmjophth-2024-001906.

Decoding Drug Discovery: Exploring A-to-Z In Silico Methods for Beginners.

Rasul H, Ghafour D, Aziz B, Hassan B, Rashid T, Kivrak A Appl Biochem Biotechnol. 2024; .

PMID: 39630336 DOI: 10.1007/s12010-024-05110-2.

Metal ions in biomedically relevant macromolecular structures.

Majorek K, Gucwa M, Murzyn K, Minor W Front Chem. 2024; 12:1426211.

PMID: 39246722 PMC: 11378719. DOI: 10.3389/fchem.2024.1426211.

CheckMyMetal (CMM): validating metal-binding sites in X-ray and cryo-EM data.

Gucwa M, Bijak V, Zheng H, Murzyn K, Minor W IUCrJ. 2024; 11(Pt 5):871-877.

PMID: 39141478 PMC: 11364027. DOI: 10.1107/S2052252524007073.

Systematic enhancement of protein crystallization efficiency by bulk lysine-to-arginine (KR) substitution.

Banayan N, Loughlin B, Singh S, Forouhar F, Lu G, Wong K Protein Sci. 2024; 33(3):e4898.

PMID: 38358135 PMC: 10868448. DOI: 10.1002/pro.4898.

References

Zhou X, Zheng W, Li Y, Pearce R, Zhang C, Bell E . I-TASSER-MTD: a deep-learning-based platform for multi-domain protein structure and function prediction. Nat Protoc. 2022; 17(10):2326-2353. DOI: 10.1038/s41596-022-00728-0. View

Barbarin-Bocahu I, Graille M . The X-ray crystallography phase problem solved thanks to AlphaFold and RoseTTAFold models: a case-study report. Acta Crystallogr D Struct Biol. 2022; 78(Pt 4):517-531. DOI: 10.1107/S2059798322002157. View

Bowler J, Sawaya M, Boyer D, Cascio D, Bali M, Eisenberg D . Micro-electron diffraction structure of the aggregation-driving N terminus of Drosophila neuronal protein Orb2A reveals amyloid-like β-sheets. J Biol Chem. 2022; 298(10):102396. PMC: 9556795. DOI: 10.1016/j.jbc.2022.102396. View

He S, Dong G, Cheng J, Wu Y, Sheng C . Strategies for designing proteolysis targeting chimaeras (PROTACs). Med Res Rev. 2022; 42(3):1280-1342. DOI: 10.1002/med.21877. View

Roell K, Reif D, Motsinger-Reif A . An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines. Front Pharmacol. 2017; 8:158. PMC: 5397413. DOI: 10.3389/fphar.2017.00158. View

Erickson J, Neidhart D, VanDrie J, Kempf D, Wang X, Norbeck D . Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. Science. 1990; 249(4968):527-33. DOI: 10.1126/science.2200122. View

Wishart D, Feunang Y, Guo A, Lo E, Marcu A, Grant J . DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017; 46(D1):D1074-D1082. PMC: 5753335. DOI: 10.1093/nar/gkx1037. View

OConnell N . Protein Ligand Interactions Using Surface Plasmon Resonance. Methods Mol Biol. 2021; 2365:3-20. DOI: 10.1007/978-1-0716-1665-9_1. View

Merk A, Bartesaghi A, Banerjee S, Falconieri V, Rao P, Davis M . Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery. Cell. 2016; 165(7):1698-1707. PMC: 4931924. DOI: 10.1016/j.cell.2016.05.040. View

10.

Price A, Howard S, Cons B . Fragment-based drug discovery and its application to challenging drug targets. Essays Biochem. 2017; 61(5):475-484. DOI: 10.1042/EBC20170029. View

11.

McAulay K, Bilsland A, Bon M . Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery. Pharmaceuticals (Basel). 2022; 15(11). PMC: 9694498. DOI: 10.3390/ph15111366. View

12.

Anderson A . The process of structure-based drug design. Chem Biol. 2003; 10(9):787-97. DOI: 10.1016/j.chembiol.2003.09.002. View

13.

Lin Z, Akin H, Rao R, Hie B, Zhu Z, Lu W . Evolutionary-scale prediction of atomic-level protein structure with a language model. Science. 2023; 379(6637):1123-1130. DOI: 10.1126/science.ade2574. View

14.

Bryant P, Pozzati G, Elofsson A . Improved prediction of protein-protein interactions using AlphaFold2. Nat Commun. 2022; 13(1):1265. PMC: 8913741. DOI: 10.1038/s41467-022-28865-w. View

15.

Keeley A, Petri L, Abranyi-Balogh P, Keseru G . Covalent fragment libraries in drug discovery. Drug Discov Today. 2020; 25(6):983-996. DOI: 10.1016/j.drudis.2020.03.016. View

16.

Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, Zidek A . Highly accurate protein structure prediction for the human proteome. Nature. 2021; 596(7873):590-596. PMC: 8387240. DOI: 10.1038/s41586-021-03828-1. View

17.

Brzezinski D, Porebski P, Kowiel M, Macnar J, Minor W . Recognizing and validating ligands with CheckMyBlob. Nucleic Acids Res. 2021; 49(W1):W86-W92. PMC: 8262754. DOI: 10.1093/nar/gkab296. View

18.

Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View

19.

Wouters O, Mckee M, Luyten J . Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. JAMA. 2020; 323(9):844-853. PMC: 7054832. DOI: 10.1001/jama.2020.1166. View

20.

Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee G . Accurate prediction of protein structures and interactions using a three-track neural network. Science. 2021; 373(6557):871-876. PMC: 7612213. DOI: 10.1126/science.abj8754. View